Alpha-1 Antitrypsin Deficiency in Patients With Cirrhosis in a US National Cohort
AATD testing rates in veterans with cirrhosis are low, and patients at high-risk are less likely to be tested. Guidelines are needed to emphasize universal AATD testing in patients with cirrhosis regardless of the presence of other risk factors.
Authors
- Tamar H. Taddei (ORCID: https://orcid.org/0000-0002-6500-1739)
- Austen Hentschel (ORCID: https://orcid.org/0000-0002-4043-8790)
- Dustin Bastaich
- Andres Samos (ORCID: https://orcid.org/0000-0002-3682-4533)
- Michael Campos (ORCID: https://orcid.org/0000-0001-5485-9062)
- Brian Garnet (ORCID: https://orcid.org/0000-0003-4031-6045)
- Binu John
- Bassam Dahman
- Sunny Sandhu
- Raphaella D Ferreira
- David E Kaplan
Institutions
- University of Miami (US)
- Virginia Commonwealth University (US)
- Florida International University (US)
- Yale University (US)
- VA Connecticut Healthcare System (US)
- Philadelphia VA Medical Center (US)
- Sky Ridge Medical Center (US)
- Miami VA Healthcare System (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Clinical and Translational Gastroenterology
- Published
- 2026-02-16
- DOI
- https://doi.org/10.14309/ctg.0000000000000995
- Primary Topic
- Protease and Inhibitor Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.00